Pfizer and Moderna executives and directors cash in billions from COVID-19 vaccine success – NEWS.com.au

Pharma honchos cashed out nearly half a billion dollars in stock as their companies raced to develop lifesaving coronavirus vaccines, a new report says.Executives and directors at 13 firms working on vaccines – including Pfizer, Moderna and Novavax – collectively sold more than 8.5 million shares worth about $US496 million ($A638 million) last year, according to theWall Street Journal (WSJ).
The pace of those sales nearly doubled from 2019, when insiders at the same companies dumped 4.7 million…

Click here to view the original article.